MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium
Links shared publicly online about this topic.
- 564total visits
MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium
The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE, a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of outpatients with bipolar disorder.
View full resource at news-medical.net
Tags: Genetic, Bipolar Disorder Medication, Drug, Eskalith, Massachusetts General Hospital, News, Genetics
Most Recently Shared on January 21, 2011 at 2:33 pm By:
Genetics News: MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium: The Ma... http://bit.ly/g3Jb1C
MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium | Latest Health & Drugs News
news.drugs-expert.com — “The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE (Clinical Health” View full resource at news.drugs-expert.com
Most Recently Shared on January 21, 2011 at 6:30 pm By:
Peter H Brown Doctor and Psychologist
MGH Bipolar CHOICE trial to evaluate effectiveness of new ... http://bit.ly/ex9z2N #bipolar
Advertisement
